Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04531046
Title Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Lymphoma Academic Research Organisation

B-cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

primary mediastinal B-cell lymphoma


axicabtagene ciloleucel

Age Groups: adult | senior
Covered Countries FRA | BEL

Facility Status City State Zip Country Details
CH Liège Recruiting Liège 4000 Belgium Details
CHU de Bordeaux - Hôpital Haut Lévêque Recruiting Bordeaux France Details
CHU Clermont Ferrand - Hôpital Estaing Recruiting Clermont-Ferrand France Details
APHP - Hôpital Henri Mondor Recruiting Créteil France Details
CHU de Dijon - Hôpital le Bocage Recruiting Dijon 21000 France Details
Hôpital Claude Huriez Recruiting Lille 59037 France Details
Hôpital Saint Eloi Recruiting Montpellier 34295 France Details
CHU de Nantes - Hôtel Dieu Recruiting Nantes 44093 France Details
APHP - Hôpital Saint Louis Recruiting Paris Cedex 10 75475 France Details
Hopital La Pitié Salpétriere Recruiting Paris France Details
Hôpital Saint Antoine Recruiting Paris France Details
Centre Hospitalier Lyon Sud Recruiting Pierre Bénite 69495 France Details
CHU de Rennes - Hôpital de Pontchaillou Recruiting Rennes 35003 France Details
IUCT Oncopole Recruiting Toulouse France Details
CHU Brabois Recruiting Vandoeuvre les Nancy 54511 France Details
Institut de Cancérologie Gustave Roussy Recruiting Villejuif France Details
*Shaded cells indicate that there was no data available from for the field